Gerald Commissiong
Tracked across 4 events · 32 articles · First seen Jun 01, 2026 · Last active Aug 12, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Gerald Commissiong, Interim Co-CEO of Wellgistics, provided key insights into the company's transformative period, strategic direction, and future growth plans.
Jun 01, 2026 · 7 articles
Business
Impact: Gerald Commissiong, Interim Co-CEO of Wellgistics, provided commentary on the strategic rationale behind the name change and the company's vision.
Jun 26, 2026 · 6 articles
Business
Impact: As Interim Co-CEO, Commissiong is the public face of the initiative, and his appearance on Fox Business may boost investor confidence in the company's leadership.
Aug 05, 2026 · 6 articles
Business
DataMeds AI, Inc. (NASDAQ:MEDS), a Health IT company, announced on August 10, 2026, that it has completed the name changes of its pharmacy and pharmacy hub subsidiaries to Corexa Pharmacy, LLC and Corexa Tech &…
Impact: Gerald Commissiong, Interim Co-CEO of DataMeds AI, is the spokesperson for the rebranding and strategic initiatives.
Aug 10, 2026 · 13 articles
ERGEN INTELLIGENCE
Track Gerald Commissiong live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard